Phenindione

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NamePhenindione
Drug Alias Name苯茚酮FenindionaPhenindionum苯茚满二酮Dindevan
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionVitamin K antagonistsVitamin K epOxide reductase complex subunit 1 inhibitors
TargetsVitamin K epOxide reductase complex subunit 1
Therapy Area/IndicationsThromboembolism
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusWithdrawn
Highest Status in ChinaN/A
Originator CompaniesSanofi-Aventis U.S. Llc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSanofi-Aventis U.S. Llc
Active IndicationsN/A
Inactive IndicationsThromboembolism

Other Information

ATC CodeB01AA02